RSC Advances
Paper
Technology and Economics (BME FIKP-BIO). Authors thank 21 S. Li, K. Huang and X. Zhang, Chem. Commun., 2014, 50,
´
´
Prof. Beata G. Vertessy (BME, Hungary) for providing access to
8878.
´
´
protein expression facilities of her laboratories. A. Lako thanks 22 I. A. Sayyed and A. Sudalai, Tetrahedron: Asymmetry, 2004, 15,
ˆ
the PhD fellowship (SPAC/BDE/08) from Hovione Farmaciencia.
3111–3116.
˜
The authors also acknowledge the Gedeon Richter Talentum 23 L. Munoz, A. M. Rodriguez, G. Rosell, M. P. Bosch and
´
Foundation for the PhD fellowship of Z. Molnar.
A. Guerrero, Org. Biomol. Chem., 2011, 9, 8171–8177.
´
´
24 J. Gonzalez-Sabın, V. Gotor and F. Rebolledo, Tetrahedron:
Asymmetry, 2002, 13, 1315–1320.
`
25 F. Poulhes, N. Vanthuyne, M. P. Bertrand, S. Gastaldi and
Notes and references
G. Gil, J. Org. Chem., 2011, 76, 7281–7286.
1 D. Ghislieri and N. J. Turner, Top. Catal., 2014, 57, 284–300. 26 B. A. Davis and D. A. Durden, Synth. Commun., 2001, 31, 569–
2 T. C. Nugent, Chiral Amine Synthesis: Methods, Developments
and Applications, Wiley-VCH, 2010.
578.
27 D. Zhu and L. Hua, Biotechnol. J., 2009, 4, 1420–1431.
3 Y. J. Kim, Y. S. Choi, S. Yang, W. R. Yang and J. H. Jeong, 28 J. Lalonde, Curr. Opin. Biotechnol., 2016, 42, 152–158.
Synlett, 2015, 26, 1981–1984.
29 K. Fesko, K. Steiner, R. Breinbauer, H. Schwab,
¨
4 Z. Chen, Y. Ma, M. He, H. Ren, S. Zhou, D. Lai, Z. Wang and
L. Jiang, Appl. Biochem. Biotechnol., 2015, 176, 2267–2278.
M. Schurmann and G. A. Strohmeier, J. Mol. Catal. B:
Enzym., 2013, 96, 103–110.
´
´
´
5 R. L. Hanson, B. L. Davis, Y. Chen, S. L. Goldberg, 30 D. Gonzalez-Martınez, V. Gotor and V. Gotor-Fernandez, Adv.
W. L. Parker, T. P. Tully, M. A. Montana and R. N. Patel,
Synth. Catal., 2019, 361, 2582–2593.
Adv. Synth. Catal., 2008, 350, 1367–1375.
31 A. Iwasaki, Y. Yamada, Y. Ikenaka and J. Hasegawa,
Biotechnol. Lett., 2003, 25, 1843–1846.
´
´
¨
´
6 E. Farkas, M. Olah, A. Foldi, J. Koti, J. Eles, J. Nagy, C. A. Gal,
´
C. Paizs, G. Hornyanszky and L. Poppe, Org. Lett., 2018, 20, 32 A. Iwasaki, Y. Yamada, N. Kizaki, Y. Ikenaka and
8052–8056. J. Hasegawa, Appl. Microbiol. Biotechnol., 2006, 69, 499–505.
7 K. R. Bailey, A. J. Ellis, R. Reiss, T. J. Snape and N. J. Turner, 33 J. Paris, A. Telzerow, N. Rıos-Lombardıa, K. Steiner,
´
´
´
¨
´
´
Chem. Commun., 2007, 44, 3640–3642.
H. Schwab, F. Morıs, H. Groger and J. Gonzalez-Sabın, ACS
8 C. K. Savile, J. M. Janey, E. C. Mundorff, J. C. Moore, S. Tam,
Sustainable Chem. Eng., 2019, 7, 5486–5493.
˚
´
´
W. R. Jarvis, J. C. Colbeck, A. Krebber, F. J. Fleitz, J. Brands, 34 A. Telzerow, J. Paris, M. Hakansson, J. Gonzalez-Sabın,
´
´
¨
´
¨
P. N. Devine, G. W. Huisman and G. J. Hughes, Science, 2010,
329, 305–309.
N. Rıos-Lombardıa, M. Schurmann, H. Groger, F. Morıs,
R. Kourist, H. Schwab and K. Steiner, ACS Catal., 2019, 9,
1140–1148.
´
9 M. J. Abrahamson, E. Vazquez-Figueroa, N. B. Woodall,
J. C. Moore and A. S. Bommarius, Angew. Chem., Int. Ed., 35 D. Koszelewski, I. Lavandera, D. Clay, D. Rozzell and
2012, 51, 3969–3972. W. Kroutil, Adv. Synth. Catal., 2008, 350, 2761–2766.
10 F. Leipold, S. Hussain, D. Ghislieri and N. J. Turner, 36 L. J. Ye, H. H. Toh, Y. Yang, J. P. Adams, R. Snajdrova and
ChemCatChem, 2013, 5, 3505–3508.
Z. Li, ACS Catal., 2015, 5, 1119–1122.
11 Northeastern University, Methods And Compositions for 37 T. Knaus, L. Cariati, M. F. Masman and F. G. Mutti, Org.
Preventing Or Treating Obesity, WO 2012/027695 A1, 2012.
Biomol. Chem., 2017, 15, 8313–8325.
12 K. Stemmer, T. D. Muller, R. D. DiMarchi, P. T. Puger and 38 F. G. Mutti, T. Knaus, N. S. Scrutton, M. Breuer and
¨
¨
M. H. Tschop, J. Clin. Invest., 2019, 129, 4058–4071.
N. J. Turner, Science, 2015, 349, 1525–1529.
39 J. A. Houwman, T. Knaus, M. Costa and F. G. Mutti, Green
Chem., 2019, 21, 3846–3857.
40 J. Liu, B. Q. W. Pang, J. P. Adams, R. Snajdrova and Z. Li,
ChemCatChem, 2017, 9, 425–431.
13 E. L. Lane, Eur. J. Neurosci., 2019, 49, 384–398.
14 M. Naoi, W. Maruyama and M. Shamoto-Nagai, J. Neural
Transm., 2020, 127, 131–147.
15 T. Winston, Methods For Treating Attention Decit
´
´
´
Hyperactivity Disorder Using A Combination Of Bupropion 41 R. S. Correia Cordeiro, N. Rıos-Lombardıa, F. Morıs,
´
´
((ꢁ)-2-(Tert-Butylamino)-1-(3-Chlorophenyl)Propan-1-One)
And Phentermine (2-Methyl-1-Phenylpropan-2-Amine), US
Pat., US 2016/0022659 A1, 2016.
R. Kourist and J. Gonzalez-Sabın, ChemCatChem, 2019, 11,
1272–1277.
42 Y. Zhang, J. Ge and Z. Liu, ACS Catal., 2015, 5, 4503–4513.
43 P. Tufvesson, J. Lima-Ramos, J. S. Jensen, N. Al-Haque,
W. Neto and J. M. Woodley, Biotechnol. Bioeng., 2011, 108,
1479–1493.
16 S. Kotagal, Paediatr. Respir. Rev., 2018, 25, 19–24.
17 S. Pattanaik, R. S. Mavuduru, A. Panda, J. L. Mathew,
M. M. Agarwal, E. C. Hwang, J. A. Lyon, S. K. Singh and
A. K. Mandal, BJU Int., 2019, 124, 27–34.
´
44 A. I. Benıtez-Mateos, M. L. Contente, S. Velasco-Lozano,
´
18 J. F. Sumowski, N. Chiaravalloti, D. Erlanger, T. Kaushik,
R. H. B. Benedict and J. Deluca, Mult. Scler. J., 2011, 17,
1141–1145.
19 S. E. Denmark, T. Weber and D. W. Piotrowski, J. Am. Chem.
Soc., 1987, 109, 2224–2225.
F. Paradisi and F. Lopez-Gallego, ACS Sustainable Chem.
Eng., 2018, 6, 13151–13159.
45 P. Tufvesson, J. Lima-Ramos, M. Nordblad and
J. M. Woodley, Org. Process Res. Dev., 2011, 15, 266–274.
}
´
´
´
´
46 L. Nagy-Gyor, E. Abahazi, V. Bodai, P. Satorhelyi, B. Erdelyi,
´
20 S. K. Talluri and A. Sudalai, Tetrahedron, 2007, 63, 9758–
9763.
D. Balogh-Weiser, C. Paizs, G. Hornyanszky and L. Poppe,
ChemBioChem, 2018, 19, 1845–1848.
40902 | RSC Adv., 2020, 10, 40894–40903
This journal is © The Royal Society of Chemistry 2020